#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prodromal Alzheimer's disease Cerebral amyloid angiopathy Peripheral T-cell lymphoma unspecified ABO haemolytic disease of newborn Short-bowel syndrome Penile cancer Desmoid tumour Neurodevelopmental disorder Transitional cell cancer of the renal pelvis and ureter Waldenstrom's macroglobulinaemia recurrent Chronic graft versus host disease in liver VEXAS syndrome Central nervous system neoplasm Pyoderma gangrenosum Candida infection More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Cytokine release syndrome – Trials in Disease Mantle cell lymphoma refractory Congenital nephrogenic diabetes insipidus – Treatment Turner’s syndrome – Treatment Sjogren’s syndrome Prader-Willi syndrome – Trials in Disease Biotinidase deficiency – Basic Information Advanced systemic mastocytosis – Diagnostics Myelodysplastic syndrome with excess blasts – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SPY002 Rbd4059 Atropine Sulfate Monohydrate Floxuridine Octreotide Hydrochloride Dasatinib Dasiglucagon Bevacizumab [11C]Az14193391 Sulodexide Perindopril Arginine Opium, Standardized Powdered Orlistat Polatuzumab Vedotin Fludeoxyglucose (18F) Datopotamab Deruxtecan Epirubicin Hydrochloride Mercaptopurine Acenocoumarol Indacaterol Maleate More therapies…

    Learn about Your Condition

    Neoplasm malignant Lymphatic malformation Type 1 diabetes mellitus Cachexia Frostbite Complicated appendicitis Peritoneal sarcoma Agitation Carotid arteriosclerosis Arthralgia Haemodynamic instability Laparotomy Coronary artery bypass Hyperparathyroidism primary Pancreatic carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Preoperative Treatment with Amivantamab, Carboplatin, and Pemetrexed for Patients with Resectable Non-Small-Cell Lung Cancer with EGFR Mutations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIA
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer
    Investigated Drugs:
    • Amivantamab
    Belgium Germany The Netherlands

  • Study on Aortic Stenosis: Evaluating Fludeoxyglucose (18F) for Patients with Conduction Disorders After Aortic Valve Procedures

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Aortic stenosis
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    France

  • Study on Topiramate for Reactivating Hidden HIV in Patients with HIV on Antiretroviral Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Topiramate
    The Netherlands

  • Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis

    Recruiting

    2 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Nmd670
    Belgium Denmark France Italy The Netherlands Poland +1

  • Study on Maintaining Remission in ANCA-Associated Vasculitis with Prednisone and Rituximab for Patients in Remission from Granulomatosis with Polyangiitis or Microscopic Polyangiitis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Prednisone
    • Rituximab
    France

  • Long-Term Safety Study of BCMACP03, BCN-CP01, and 19CP02 for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, CLL, SLL, or Multiple Myeloma

    Recruiting

    3 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • 19Cp02
    • Bcmacp03
    Belgium Finland The Netherlands Spain
Previous Page
1 … 504 505 506 507 508 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!